Jörg Lauermann

Jörg Lauermann

Auto-generated profile, based on publicly available information

Jörg Lauermann

Department of Internal Medicine, Ryhov County Hospital, Jönköping, Sweden

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2021 in Circulation
Verified
Journal Article
Closed access
PDF file
OFOle Fröbert
Ole Fröbert
MGMatthias Götberg
Matthias Götberg
DEDavid Erlinge
David Erlinge
ZAZubair Akhtar
Zubair Akhtar
ECEvald H. Christiansen
Evald H. Christiansen
JPJohn Pernow
John Pernow
Background: Observational and small, randomized studies suggest that influenza vaccine may reduce future cardiovascular events in patients with cardiovascular disease. Methods: We conducted an investigator-initiated, randomized, double-blind trial to compare inactivated influenza vaccine with saline placebo administered shortly after myocardial infarction (MI; 99.7% of patients) or high-risk stable coronary heart disease (0.3%). The primary end point was the composite of all-cause death, MI, or stent thrombosis at 12 months. A hierarchical testing strategy was used for the key secondary end points: all-cause death, cardiovascular death, MI, and stent thrombosis. Results: Because of the COVID-19 pandemic, the data safety and monitoring board recommended to halt the trial before attaining the prespecified sample size. Between October 1, 2016, and March 1, 2020, 2571 participants were randomized at 30 centers across 8 countries. Participants assigned to influenza vaccine totaled 1290 and individuals assigned to placebo equaled 1281; of these, 2532 received the study treatment (1272 influenza vaccine and 1260 placebo) and were included in the modified intention to treat analysis. Over the 12-month follow-up, the primary outcome occurred in 67 participants (5.3%) assigned influenza vaccine and 91 participants (7.2%) assigned placebo (hazard ratio, 0.72 [95% CI, 0.52–0.99]; P =0.040). Rates of all-cause death were 2.9% and 4.9% (hazard ratio, 0.59 [95% CI, 0.39–0.89]; P =0.010), rates of cardiovascular death were 2.7% and 4.5%, (hazard ratio, 0.59 [95% CI, 0.39–0.90]; P =0.014), and rates of MI were 2.0% and 2.4% (hazard ratio, 0.86 [95% CI, 0.50–1.46]; P =0.57) in the influenza vaccine and placebo groups, respectively. Conclusions: Influenza vaccination early after an MI or in high-risk coronary heart disease resulted in a lower risk of a composite of all-cause death, MI, or stent thrombosis, and a lower risk of all-cause death and cardiovascular death, as well, at 12 months compared with placebo. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02831608.

29 June 2023 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
SMStephen Malmberg
Stephen Malmberg
JLJörg Lauermann
Jörg Lauermann
PKPatric Karlström
Patric Karlström
DGDario Gulin
Dario Gulin
NBNeshro Barmano
Neshro Barmano
The adenosine-requiring physiological index fractional flow reserve (FFR) is the gold-standard method for determining the significance of intermediate lesions, while the resting full-cycle ratio (RFR) is a novel nonhyperaemic index without the need for adenosine administration. The aim of this study was to investigate the degree of concordance between RFR and FFR in indicating the need for revascularisation in patients with intermediate coronary lesions. This was a retrospective, registry-based study utilising data from the SWEDEHEART registry. Patients treated at Ryhov County Hospital in Jönköping, Sweden, between the 1st of January 2020 and the 30th of September 2021, were included. The degree of correlation and concordance between RFR and FFR was determined, both when used with a single cut-off (significant stenosis if RFR ≤0.89) and with a hybrid approach (significant stenosis if RFR ≤0.85, not significant if RFR ≥0.94, and FFR measurement when RFR was in the grey zone 0.86–0.93). The study population consisted of 143 patients with 200 lesions. The overall correlation between FFR and RFR was significant (r = 0.715, R2 = 0.511, ). A strong correlation was seen for lesions in the left anterior descending artery (LAD) and the left circumflex artery (LCX) (r = 0.748 and 0.742, respectively, both ), while the correlation in the right coronary artery (RCA) was moderate (r = 0.524, ). The overall concordance between FFR and RFR using a single cut-off was 79.0%. With a hybrid cut-off approach, the degree of concordance was 91%, with no need of adenosine in 50.5% of the lesions. In conclusion, there was a strong correlation and a high degree of concordance between FFR and RFR in determining the significance of a stenosis. The use of a hybrid approach could improve the identification of physiologically significant stenoses while minimising the use of adenosine.

1 June 2018 in American Heart Journal
Verified
Journal Article
Closed access
DLDaniel Lindholm
Daniel Lindholm
SJStefan James
Stefan James
JAJonas Andersson
Jonas Andersson
OBOscar Ö Braun
Oscar Ö Braun
SHSusanne Heller
Susanne Heller
CVChristoph Varenhorst
Christoph Varenhorst

14 August 2014 in Scandinavian Cardiovascular Journal
Verified
Journal Article
Open access
PDF file
AWAnna-Maria Wahlberg
Anna-Maria Wahlberg
MAMagdalena Alenström
Magdalena Alenström
SUStina Udin
Stina Udin
TJTore Johansson
Tore Johansson
ALAnna Lundgren
Anna Lundgren
ABAnna Björklund
Anna Björklund
(2014). Annual report SWEDEHEART 2012. Scandinavian Cardiovascular Journal: Vol. 48, No. sup63, pp. 2-133.